期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

纳米细菌的生物学特性及其与疾病的关系 被引量：2

Nanobacteria′s Bionomics and its Relationship with Disease
下载PDF
导出
摘要 纳米细菌是一种新近发现的生物体,与传统的细菌相比,有其独特的生物学特性:生物矿化作用。随着对纳米细菌认识的加深,发现纳米细菌与多种疾病有着密切的关系。 Nanobacteria（NB） is a new found organism, which has its own biology character and biomineralization compared with traditional bacteria. With the development of recognition about it, we found that NB has a close relationship with many kinds of disease.
作者 赵家锋 叶观瑞
机构地区 广东医学院 广东省高州市人民医院肝胆外科
出处 《医学综述》 2006年第8期459-460,共2页 Medical Recapitulate
关键词 纳米细菌 生物矿化 疾病 Nanobacteria Biomineralization Disease
分类号 R379.9 [医药卫生—病原生物学]
  • 相关文献

参考文献19

  • 1Kajander E, Olavi and ciftcioglu Neva. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification andstone formstion[J]. Proc Natl Acad Sci USA, 1998,95 (14) : 8274-8279.
  • 2Vainshtein MB, Kudriashova EB. About nannobacteria [ J ]. Mikrobiologila,2000,69(2) : 163-174.
  • 3CisarJO, Xu DQ, Thompson J, et al. An alternative interpretation of nanobacteria- induced biomineralization[J]. Proc Natl Acad Sci USA,2000,97(21) :11511-11515.
  • 4Hjelle JT,Marcia A,Millar Hjelle MA, et al.Endotoxin and nanobacteria in polyeystic kidney disease [J]. Kidney Int, 2000, 57 (6) : 2360-2374.
  • 5Ciftcioglu N, Miller-Hjelle MA, Hjelle Jr, et al. Inhibition of nanobac-teria by antimicrobial drugs as a measured by a modified microdilution method [ J ]. Antimicmb Agents Chemother, 2002,46 (7):72077 -72086.
  • 6Kajander EO, Ciftcioglu N, Nanobacteria: an alternative mechanism for pathogenic intrs-and extracellular calcification and stone formation[J].Proc Nail Acad USA, 1998,95 (14):8274-8279.
  • 7KajanderEO, Ciftcioglu N, Mller Hjelle MA, et al. Nanobacteria: controversial pathogens in nephrolithiasis and polycystlc kidney disease [J]. Curr Opin Nephrol Hypertens, 2001,10(3) : 445-452.
  • 8Cifctsoglu NM,Bjorldund K, Kuorikoski K, et al. Nanobacteria: an infectious cause for kidney stone formation[J]. Kidney Int, 1999,56(5):1893-1898.
  • 9Garcia-Cuerpo E, Kajander O, Cidtcioglu N,et al. Nanobaeteria: An experimental neolithosenesis model[J]. Arch Esp Urol, 2000,53 (4):291-303.
  • 10李永国,文宇,杨竹林,魏红,刘威,谭爱玲,吴晓瑛,王群伟,黄生福,Kajander EO,Ciftcioglu N.胆汁纳米细菌的培养与鉴定[J].中华医学杂志,2002,82(22):1557-1560. 被引量：17

二级参考文献31

共引文献37

同被引文献25

  • 1王利民,沈文律,张士莲.纳米细菌研究[J].世界华人消化杂志,2005,13(23):2783-2787. 被引量：3
  • 2王学军,杨竹林,文宇,魏红,刘威,李永国,E.Olavi Kajander.慢性肝病、原发性肝癌病人血清、肝组织纳米细菌的检测[J].中华肝胆外科杂志,2006,12(3):193-196. 被引量：7
  • 3刘建文,李月辉,王健春.纳米细菌——一种新的病原微生物[J].中国兽医杂志,2006,42(9):64-64. 被引量：1
  • 4CISAR J O, XU De-qi, THOMPSON J, et al. An alternative interpretation of Nanobacteria-induced biomimeralization[J]. Proc Natl Acad Sci USA, 2000,97(21): 11511-11515.
  • 5WANG Li-min, SHEN Wen-lu. An animal model of black pigment gallstones caused by nanobacteria[J]. Dige Dise and Sci , 2006, 51(6):1126-1132.
  • 6YASIN A, MEHTAP H A, MESRUR S S, et al. The role of nanobacteria in cardiac sarcoidosis[J]. Correspondence, 2006(1): 1180.
  • 7TURGUT D. Is there any relation of nanobacteria with periodontal diseases[J]. Medi Hypo, 2008(70): 36-39.
  • 8KAJANDER E O, BJORKLUND M, CIFTCIOGLU N. Mineralization by nanobacteria[J]. Proc SPIE Int Soc Opt Eng, 1998, 3441:86.
  • 9CIFTCIOGLU N, MILLER M A, HJELLE J T, et al. Inhibition of nanohacteria by antimicrobial drugs as measured by a modified microdilution method[J]. Antimicrob Agents Chemo Ther, 2002, 46(7) :2077-2086.
  • 10KAJANDER E O, CIFTCIOGLU N, AHO K, et al. Characteristics of nanobacteria and their possible role in stone formation[J]. Urol Res, 2003(31): 47-54

引证文献2

二级引证文献3

医学综述
2006年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部